Ortiz cautioned that the medications should be used under a doctors supervision, warning about people obtaining prescriptions through online pharmacies without appropriate oversight
Furthermore, in January 2025, the FDA approved semaglutide (Ozempic ) for reducing the risk of kidney failure and disease progression in patients with diabetes and chronic kidney disease (CKD), making it the first GLP-1 agent indicated for the treatment of CKD (Perkovic et al., 2024)
[DOI] [PubMed] [Google Scholar] 57.Sever B., Soybir H., Grgl S., Cantrk Z., Altntop M.D
GLP-1 treatments are projected to lead to an annual revenue reduction of $30$55 billion by 20302034 for the food and beverage industry, with consumers taking in 21% fewer calories and spending 31% less on groceries, said Lucas Ferreira, who covers Latin America Food, Beverages and Agribusiness at J.P
But the amount of weight you lose on tirzepatide typically depends on your dosage